Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Systemo-pulmonary shunting and acute chest syndrome in a patient with SC sickle-cell disease.

Schlemmer F, Gellen-Dautremer J, Carette MF, de Prost N, Spagnolo S, Deux JF, Fartoukh M, Naccache JM, Habibi A, Mahevas M, Bartolucci P, Mekontso Dessap A, Maitre B.

Respir Med Res. 2019 Nov 21;77:21-23. doi: 10.1016/j.resmer.2019.11.001. [Epub ahead of print] No abstract available.

PMID:
32036282
2.

Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal.

Thein SL, Pirenne F, Fasano RM, Habibi A, Bartolucci P, Chonat S, Hendrickson JE, Stowell SR.

Haematologica. 2020 Mar;105(3):539-544. doi: 10.3324/haematol.2019.224709. Epub 2020 Feb 6. No abstract available.

3.

Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy.

Roumenina LT, Chadebech P, Bodivit G, Vieira-Martins P, Grunenwald A, Boudhabhay I, Poillerat V, Pakdaman S, Kiger L, Jouard A, Audureau E, Pirenne F, Galactéros F, Frémeaux-Bacchi V, Bartolucci P.

Am J Hematol. 2020 Jan 28. doi: 10.1002/ajh.25742. [Epub ahead of print]

PMID:
31990387
4.

Primary Hyperparathyroidism in Sickle Cell Disease: An Unknown Complication of the Disease in Adulthood.

Denoix E, Bomahou C, Clavier L, Ribeil JA, Lionnet F, Bartolucci P, Courbebaisse M, Pouchot J, Arlet JB.

J Clin Med. 2020 Jan 22;9(2). pii: E308. doi: 10.3390/jcm9020308.

5.

Tubular Acidification Defect in Adults with Sickle Cell Disease.

Cazenave M, Audard V, Bertocchio JP, Habibi A, Baron S, Prot-Bertoye C, Berkenou J, Maruani G, Stehlé T, Cornière N, Ayari H, Friedlander G, Galacteros F, Houillier P, Bartolucci P, Courbebaisse M.

Clin J Am Soc Nephrol. 2020 Jan 7;15(1):16-24. doi: 10.2215/CJN.07830719. Epub 2019 Dec 10.

PMID:
31822527
6.

Beneficial effects of endurance exercise training on skeletal muscle microvasculature in sickle cell disease patients.

Merlet AN, Messonnier LA, Coudy-Gandilhon C, Béchet D, Gellen B, Rupp T, Galactéros F, Bartolucci P, Féasson L.

Blood. 2019 Dec 19;134(25):2233-2241. doi: 10.1182/blood.2019001055.

PMID:
31742587
7.

Cerebral fat embolism in sickle cell disease.

Gendreau S, Scholer M, Cecchini J, Habibi A, Razazi K, De Prost N, Carteaux G, Bartolucci P, Gendre T, Brugieres P, Hodel J, Mekontso Dessap A.

Am J Hematol. 2020 Feb;95(2):E41-E45. doi: 10.1002/ajh.25686. Epub 2019 Nov 29. No abstract available.

PMID:
31736103
8.

The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction.

Roumenina LT, Bartolucci P, Pirenne F.

Transfus Med Rev. 2019 Oct;33(4):225-230. doi: 10.1016/j.tmrv.2019.09.007. Epub 2019 Oct 18. Review.

PMID:
31672341
9.

Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease.

Savale L, Habibi A, Lionnet F, Maitre B, Cottin V, Jais X, Chaouat A, Artaud-Macari E, Canuet M, Prevot G, Chantalat-Auger C, Montani D, Sitbon O, Galacteros F, Simonneau G, Parent F, Bartolucci P, Humbert M.

Eur Respir J. 2019 Dec 4;54(6). pii: 1900585. doi: 10.1183/13993003.00585-2019. Print 2019 Dec. Erratum in: Eur Respir J. 2020 Jan 30;55(1):.

PMID:
31537700
10.

Venoarterial Extracorporeal Membrane Oxygenation in Sickle Cell Disease for Urgent Cardiac Surgery.

de Roux Q, Maghrebi S, Fiore A, Arminot-Fremaux M, Dessalle T, Lim P, Folliguet T, Bartolucci P, Langeron O, Mongardon N.

Ann Thorac Surg. 2020 Mar;109(3):e161-e162. doi: 10.1016/j.athoracsur.2019.05.093. Epub 2019 Jul 27.

PMID:
31362014
11.

Survival and specific outcome of sickle cell disease patients after renal transplantation.

Gérardin C, Moktefi A, Couchoud C, Duquesne A, Ouali N, Gataut P, Karras A, Anglicheau D, Lefaucheur C, Figueres L, Albano L, Lionet A, Novion M, Ziliotis MJ, Louis M, Del Bello A, Matignon M, Dahan K, Habibi A, Galacteros F, Bartolucci P, Grimbert P, Audard V.

Br J Haematol. 2019 Dec;187(5):676-680. doi: 10.1111/bjh.16113. Epub 2019 Jul 26.

PMID:
31348518
12.

Molecular testing for respiratory pathogens in sickle cell disease adult patients presenting with febrile acute chest syndrome.

Raffetin A, Melica G, Audureau E, Habibi A, Decousser JW, Fourati S, Razazi K, Lepeule R, Guillaud C, Khellaf M, Bartolucci P, Gallien S.

Med Mal Infect. 2020 Feb;50(1):49-56. doi: 10.1016/j.medmal.2019.04.391. Epub 2019 May 11.

PMID:
31088757
13.

Physiological Evaluation for Endurance Exercise Prescription in Sickle Cell Disease.

Messonnier LA, Gellen B, Lacroix R, Peyrot S, Rupp T, Mira J, Peyrard A, Berkenou J, Galactéros F, Bartolucci P, Féasson L.

Med Sci Sports Exerc. 2019 Sep;51(9):1795-1801. doi: 10.1249/MSS.0000000000001993.

PMID:
30920486
14.

Intracranial aneurysms in sickle cell disease: Aneurysms characteristics and modalities of endovascular approach to treat these patients.

Gallas S, Tuilier T, Ebrahiminia V, Bartolucci P, Hodel J, Gaston A.

J Neuroradiol. 2019 Mar 20. pii: S0150-9861(19)30200-7. doi: 10.1016/j.neurad.2019.03.001. [Epub ahead of print] Review.

PMID:
30904450
15.

Characteristics of Moyamoya Syndrome in Sickle-Cell Disease by Magnetic Resonance Angiography: An Adult-Cohort Study.

Kauv P, Gaudré N, Hodel J, Tuilier T, Habibi A, Oppenheim C, Edjlali M, Hervé D, Calvet D, Bartolucci P.

Front Neurol. 2019 Jan 22;10:15. doi: 10.3389/fneur.2019.00015. eCollection 2019.

16.

Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.

Bao EL, Lareau CA, Brugnara C, Fulcher IR, Barau C, Moutereau S, Habibi A, Badaoui B, Berkenou J, Bartolucci P, Galactéros F, Platt OS, Mahaney M, Sankaran VG.

Am J Hematol. 2019 May;94(5):522-527. doi: 10.1002/ajh.25421. Epub 2019 Feb 6.

PMID:
30680775
17.

Moderate-intensity endurance-exercise training in patients with sickle-cell disease without severe chronic complications (EXDRE): an open-label randomised controlled trial.

Gellen B, Messonnier LA, Galactéros F, Audureau E, Merlet AN, Rupp T, Peyrot S, Martin C, Féasson L, Bartolucci P; EXDRE collaborative study group.

Lancet Haematol. 2018 Nov;5(11):e554-e562. doi: 10.1016/S2352-3026(18)30163-7.

PMID:
30389037
18.

Severe, non specific symptoms in non-typhoidal Salmonella infections in adult patients with sickle cell disease: a retrospective multicentre study.

Guery R, Habibi A, Arlet JB, Lionnet F, de Lastours V, Decousser JW, Mainardi JL, Razazi K, Baranes L, Bartolucci P, Godeau B, Galacteros F, Michel M, Mahevas M.

Infect Dis (Lond). 2018 Nov - Dec;50(11-12):822-830. doi: 10.1080/23744235.2018.1500706. Epub 2018 Oct 14.

PMID:
30317897
19.

Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease.

Turpin M, Chantalat-Auger C, Parent F, Driss F, Lionnet F, Habibi A, Maître B, Huertas A, Jaïs X, Weatherald J, Montani D, Sitbon O, Simonneau G, Galactéros F, Humbert M, Bartolucci P, Savale L.

Eur Respir J. 2018 Oct 10;52(4). pii: 1800272. doi: 10.1183/13993003.00272-2018. Print 2018 Oct.

PMID:
30305330
20.

A common functional PIEZO1 deletion allele associates with red blood cell density in sickle cell disease patients.

Ilboudo Y, Bartolucci P, Garrett ME, Ashley-Koch A, Telen M, Brugnara C, Galactéros F, Lettre G.

Am J Hematol. 2018 Nov;93(11):E362-E365. doi: 10.1002/ajh.25245. Epub 2018 Sep 9. No abstract available.

21.

Low fetal hemoglobin percentage is associated with silent brain lesions in adults with homozygous sickle cell disease.

Calvet D, Tuilier T, Mélé N, Turc G, Habibi A, Abdallah NA, Majhadi L, Hemery F, Edjlali M, Galacteros F, Bartolucci P.

Blood Adv. 2017 Dec 1;1(26):2503-2509. doi: 10.1182/bloodadvances.2017005504. eCollection 2017 Dec 12.

22.

Low-impact laparoscopic cholecystectomy is associated with decreased postoperative morbidity in patients with sickle cell disease.

de'Angelis N, Abdalla S, Carra MC, Lizzi V, Martínez-Pérez A, Habibi A, Bartolucci P, Galactéros F, Laurent A, Brunetti F.

Surg Endosc. 2018 May;32(5):2300-2311. doi: 10.1007/s00464-017-5925-y. Epub 2017 Nov 2.

PMID:
29098436
23.

Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients.

Haymann JP, Hammoudi N, Stankovic Stojanovic K, Galacteros F, Habibi A, Avellino V, Bartolucci P, Benzerara Y, Arlet JB, Djebbar M, Letavernier E, Grateau G, Tabibzadeh N, Girshovich A, Chaignon M, Girot R, Levy P, Lionnet F.

Br J Haematol. 2017 Dec;179(5):820-828. doi: 10.1111/bjh.14969. Epub 2017 Oct 19.

PMID:
29048108
24.

Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.

Narbey D, Habibi A, Chadebech P, Mekontso-Dessap A, Khellaf M, Lelièvre JD, Godeau B, Michel M, Galactéros F, Djoudi R, Bartolucci P, Pirenne F.

Am J Hematol. 2017 Dec;92(12):1340-1348. doi: 10.1002/ajh.24908. Epub 2017 Oct 31.

25.

Determination of hydroxyurea in human plasma by HPLC-UV using derivatization with xanthydrol.

Legrand T, Rakotoson MG, Galactéros F, Bartolucci P, Hulin A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Oct 1;1064:85-91. doi: 10.1016/j.jchromb.2017.09.008. Epub 2017 Sep 7.

PMID:
28915422
26.

A clinical risk score for pulmonary artery thrombosis during acute chest syndrome in adult patients with sickle cell disease.

Winchenne A, Cecchini J, Deux JF, De Prost N, Razazi K, Carteaux G, Galacteros F, Habibi A, Bartolucci P, Melica G, Khellaf M, Michel M, Maitre B, Mekontso Dessap A.

Br J Haematol. 2017 Nov;179(4):627-634. doi: 10.1111/bjh.14914. Epub 2017 Sep 14.

PMID:
28905364
27.

Sickle cell disease and albuminuria: recent advances in our understanding of sickle cell nephropathy.

Audard V, Bartolucci P, Stehlé T.

Clin Kidney J. 2017 Aug;10(4):475-478. doi: 10.1093/ckj/sfx027. Epub 2017 Apr 21.

28.

Thrombolytic therapy for the treatment of acute ischaemic stroke in adults with homozygous sickle cell disease.

Majhadi L, Calvet D, Rosso C, Bartolucci P.

BMJ Case Rep. 2017 Jul 28;2017. pii: bcr-2017-220011. doi: 10.1136/bcr-2017-220011.

29.

Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.

Pirenne F, Bartolucci P, Habibi A.

Transfus Clin Biol. 2017 Sep;24(3):227-231. doi: 10.1016/j.tracli.2017.05.016. Epub 2017 Jun 29.

PMID:
28669521
30.

Genome-wide association study of erythrocyte density in sickle cell disease patients.

Ilboudo Y, Bartolucci P, Rivera A, Sedzro JC, Beaudoin M, Trudel M, Alper SL, Brugnara C, Galactéros F, Lettre G.

Blood Cells Mol Dis. 2017 Jun;65:60-65. doi: 10.1016/j.bcmd.2017.05.005. Epub 2017 May 13.

PMID:
28552477
31.

Telomere attrition in sickle cell anemia.

Mekontso Dessap A, Cecchini J, Chaar V, Marcos E, Habibi A, Bartolucci P, Ghaleh B, Galacteros F, Adnot S.

Am J Hematol. 2017 Jun;92(6):E112-E114. doi: 10.1002/ajh.24721. Epub 2017 Apr 18. No abstract available.

32.

Improved Fetal Hemoglobin With mTOR Inhibitor-Based Immunosuppression in a Kidney Transplant Recipient With Sickle Cell Disease.

Gaudre N, Cougoul P, Bartolucci P, Dörr G, Bura-Riviere A, Kamar N, Del Bello A.

Am J Transplant. 2017 Aug;17(8):2212-2214. doi: 10.1111/ajt.14263. Epub 2017 Mar 30.

33.

Gene Therapy in a Patient with Sickle Cell Disease.

Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, Caccavelli L, Neven B, Bourget P, El Nemer W, Bartolucci P, Weber L, Puy H, Meritet JF, Grevent D, Beuzard Y, Chrétien S, Lefebvre T, Ross RW, Negre O, Veres G, Sandler L, Soni S, de Montalembert M, Blanche S, Leboulch P, Cavazzana M.

N Engl J Med. 2017 Mar 2;376(9):848-855. doi: 10.1056/NEJMoa1609677.

34.

Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.

Deux JF, Audard V, Brugières P, Habibi A, Manea EM, Guillaud-Danis C, Godeau B, Galactéros F, Stehlé T, Lang P, Grimbert P, Audureau E, Rahmouni A, Bartolucci P.

Am J Kidney Dis. 2017 Jan;69(1):51-59. doi: 10.1053/j.ajkd.2016.07.027. Epub 2016 Sep 20.

PMID:
27663041
35.

Reversible kidney iron accumulation in a patient with sickle cell disease treated with hydroxyurea.

Stehlé T, Bartolucci P, Bouanane M, Galacteros F, Dudreuilh C, Grimbert P, Deux JF, Audard V.

Am J Hematol. 2016 Dec;91(12):1283-1284. doi: 10.1002/ajh.24544. Epub 2016 Oct 14. No abstract available.

36.

A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease.

Mekontso Dessap A, Pirenne F, Razazi K, Moutereau S, Abid S, Brun-Buisson C, Maitre B, Michel M, Galacteros F, Bartolucci P, Habibi A.

Am J Hematol. 2016 Dec;91(12):1181-1184. doi: 10.1002/ajh.24537. Epub 2016 Sep 7.

37.

Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.

Bartolucci P, Habibi A, Khellaf M, Roudot-Thoraval F, Melica G, Lascaux AS, Moutereau S, Loric S, Wagner-Ballon O, Berkenou J, Santin A, Michel M, Renaud B, Lévy Y, Galactéros F, Godeau B.

EBioMedicine. 2016 Aug;10:305-11. doi: 10.1016/j.ebiom.2016.06.038. Epub 2016 Jun 29.

38.

Dense red blood cell and oxygen desaturation in sickle-cell disease.

Di Liberto G, Kiger L, Marden MC, Boyer L, Poitrine FC, Conti M, Rakotoson MG, Habibi A, Khorgami S, Vingert B, Maitre B, Galacteros F, Pirenne F, Bartolucci P.

Am J Hematol. 2016 Oct;91(10):1008-13. doi: 10.1002/ajh.24467. Epub 2016 Aug 4.

39.

Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.

Habibi A, Mekontso-Dessap A, Guillaud C, Michel M, Razazi K, Khellaf M, Chami B, Bachir D, Rieux C, Melica G, Godeau B, Galacteros F, Bartolucci P, Pirenne F.

Am J Hematol. 2016 Oct;91(10):989-94. doi: 10.1002/ajh.24460. Epub 2016 Jul 14.

40.

Pulmonary and cerebral microvasculopathy in a patient with sickle cell disease: A role for dense red blood cells?

Ségot A, Deux JF, Thuillier T, Maitre B, Galactéros F, Bartolucci P.

Am J Hematol. 2016 Sep;91(9):963-4. doi: 10.1002/ajh.24413. Epub 2016 Jul 14. No abstract available.

41.

Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients.

Ibanez C, Habibi A, Mekontso-Dessap A, Chadebech P, Chami B, Bierling P, Galactéros F, Rieux C, Nataf J, Bartolucci P, Peyrard T, Pirenne F.

Transfusion. 2016 Jul;56(7):1828-33. doi: 10.1111/trf.13611. Epub 2016 May 3.

PMID:
27145018
42.

Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients.

Nielsen L, Canouï-Poitrine F, Jais JP, Dahmane D, Bartolucci P, Bentaarit B, Gellen-Dautremer J, Remy P, Kofman T, Matignon M, Suberbielle C, Jacquelinet C, Wagner-Ballon O, Sahali D, Lang P, Damy T, Galactéros F, Grimbert P, Habibi A, Audard V.

Br J Haematol. 2016 Jul;174(1):148-52. doi: 10.1111/bjh.14040. Epub 2016 Mar 17.

PMID:
26992059
43.

Successful Treatment of Lung Calciphylaxis With Sodium Thiosulfate in a Patient With Sickle Cell Disease: A Case Report.

Arrestier R, Dudreuilh C, Remy P, Boulahia G, Bentaarit B, Leibler C, Adedjouma A, Kofman T, Matignon M, Sahali D, Dufresne R, Deux JF, Colin C, Grimbert P, Lang P, Bartolucci P, Maitre B, Tran Van Nhieu J, Audard V.

Medicine (Baltimore). 2016 Feb;95(6):e2768. doi: 10.1097/MD.0000000000002768.

44.

Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients.

Dumas G, Habibi A, Onimus T, Merle JC, Razazi K, Mekontso Dessap A, Galactéros F, Michel M, Frémeaux Bacchi V, Noizat Pirenne F, Bartolucci P.

Blood. 2016 Feb 25;127(8):1062-4. doi: 10.1182/blood-2015-09-669770. Epub 2016 Jan 12. No abstract available.

PMID:
26758914
45.

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

Bartolucci P, Habibi A, Stehlé T, Di Liberto G, Rakotoson MG, Gellen-Dautremer J, Loric S, Moutereau S, Sahali D, Wagner-Ballon O, Remy P, Lang P, Grimbert P, Audureau E, Godeau B, Galacteros F, Audard V.

J Am Soc Nephrol. 2016 Jun;27(6):1847-53. doi: 10.1681/ASN.2014111126. Epub 2015 Nov 19.

46.

Haematological determinants of cardiac involvement in adults with sickle cell disease.

Damy T, Bodez D, Habibi A, Guellich A, Rappeneau S, Inamo J, Guendouz S, Gellen-Dautremer J, Pissard S, Loric S, Wagner-Ballon O, Godeau B, Adnot S, Dubois-Randé JL, Hittinger L, Galactéros F, Bartolucci P.

Eur Heart J. 2016 Apr 7;37(14):1158-1167. doi: 10.1093/eurheartj/ehv555. Epub 2015 Oct 29.

PMID:
26516176
47.

[Symptomatic extramedullary haematopoiesis in β-thalassemia: A retrospective single centre study].

Maazoun F, Gellen Dautremer J, Boutekadjirt A, Pissard S, Habibi A, Bachir D, Rahmouni A, Bartolucci P, Debbache K, Lagrange JL, Michel M, Galacteros F.

Rev Med Interne. 2016 Jan;37(1):5-12. doi: 10.1016/j.revmed.2015.07.005. Epub 2015 Sep 26. French.

PMID:
26410419
48.

First Ischemic Stroke in Sickle-Cell Disease: Are There Any Adult Specificities?

Calvet D, Bernaudin F, Gueguen A, Hosseini H, Habibi A, Galactéros F, Bartolucci P.

Stroke. 2015 Aug;46(8):2315-7. doi: 10.1161/STROKEAHA.115.010153. Epub 2015 Jul 14.

PMID:
26173728
49.

[French guidelines for the management of adult sickle cell disease: 2015 update].

Habibi A, Arlet JB, Stankovic K, Gellen-Dautremer J, Ribeil JA, Bartolucci P, Lionnet F; centre de référence maladies rares « syndromes drépanocytaires majeurs ».

Rev Med Interne. 2015 May 11;36(5 Suppl 1):5S3-84. doi: 10.1016/S0248-8663(15)60002-9. French.

PMID:
26007619
50.

Biological parameters predictive of percent dense red blood cell decrease under hydroxyurea.

Rakotoson MG, Di Liberto G, Audureau E, Habibi A, Fauroux C, Khorgami S, Hulin A, Loric S, Noizat-Pirenne F, Galacteros F, Bartolucci P.

Orphanet J Rare Dis. 2015 May 9;10:57. doi: 10.1186/s13023-015-0272-3.

Supplemental Content

Loading ...
Support Center